Tuesday, Sep 28, 2021
Focus on the big picture

Novo Nordisk Raises Forecasts on New Obesity Drug

Bloomberg, 05 Aug 2021
Aug.05 -- Lars Fruergaard Jorgensen, Novo Nordisk chief executive officer, discusses first half earnings results. The Danish drug-maker raised its profit and ...
Related Articles